Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy
Keywords: شیمی درمانی; BRCA1; Base excision repair; ATM; DNA-PK; Small molecule inhibitors; Synthetic lethality; Cisplatin; Chemopotentiation;